Why Hologic (HOLX) Outpaced the Stock Market Today

Stock Performance - Hologic (HOLX) closed at $71 19, marking a +1 17% increase from the previous day, outperforming the S&P 500's 0 61% gain and the Nasdaq's 1 28% gain [1] - Over the past month, HOLX stock dropped by 3 18%, underperforming the Medical sector's gain of 1 64% and the S&P 500's gain of 2 08% [1] Earnings and Revenue Expectations - The company is expected to report Q4 2025 EPS of$ 1 01, a 3 06% increase from the prior-year quarter, with revenue expected to be $1 03 billion, up 1 39% year-over-year [2] - Full-year Zacks Consensus Estimates predict earnings of$ 4 27 per share and revenue of $4 17 billion, representing year-over-year changes of +4 66% and +3 48%, respectively [3] Analyst Estimates and Revisions - Recent revisions to analyst estimates reflect near-term business trends, with positive alterations indicating optimism about the company's profitability [3] - Over the past month, the Zacks Consensus EPS estimate for HOLX has moved 0 31% lower, and the stock currently holds a Zacks Rank of 3 (Hold) [5] Valuation Metrics - HOLX has a Forward P/E ratio of 16 47, representing a discount compared to the industry average Forward P/E of 28 55 [6] - The company's PEG ratio is 2 4, slightly higher than the Medical - Instruments industry average of 2 26 [7] Industry Performance - The Medical - Instruments industry, part of the Medical sector, has a Zacks Industry Rank of 60, placing it in the top 24% of all industries [7] - Research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]